Glioma: all 1,425 studies
Page 14 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain MetastasesStatus unknownNCT00276783Phase 2
- Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasCompletedNCT00276640Not applicable
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryStatus unknownNCT00275067Phase 1/2
- ZD6474 to Treat Advanced Brain Cancer in PatientsCompletedNCT00272350Phase 1
- Vorinostat and Temozolomide in Treating Patients With Malignant GliomasActive, not recruitingNCT00268385Phase 1
- Cognitive Rehabilitation of Glioma PatientsStatus unknownNCT00256425Phase 3
- Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic AcidCompletedNCT00241670Phase 3
- Study of Brain Tumors (Tectal Tumors) Using Magnetic Resonance ImagingWithdrawnNCT00229814
- Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade GliomaCompletedNCT00213278Phase 2
- The Roles of Tissue Factor in Malignant GliomasCompletedNCT00201903
- A Study of LY317615 in Patients With Brain TumorsCompletedNCT00190723Phase 2
- Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant GliomaCompletedNCT00185861Phase 1
- Radiation Therapy or Temozolomide in Treating Patients With GliomasCompletedNCT00182819Phase 3
- Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaCompletedNCT00179881Phase 2
- Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00165477Phase 2
- Prolonged Daily Temozolomide for Low-Grade GliomaCompletedNCT00165360Phase 2
- G207 Followed by Radiation Therapy in Malignant GliomaCompletedNCT00157703Phase 1
- Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and AdolescentsCompletedNCT00147160Phase 2
- Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)CompletedNCT00137488
- Comparative 2-D Tumor Analysis in Familial GliomasCompletedNCT00125710
- Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing RadiotherapyCompletedNCT00125697
- High Light and Low Light Dose PDT in GliomaCompletedNCT00118222Phase 3
- 131-I-TM-601 Study in Adults With Recurrent High-Grade GliomaStatus unknownNCT00114309Phase 2
- Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
- Enzastaurin to Treat Recurrent Brain TumorTerminatedNCT00108056Phase 1
- Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem GliomaTerminatedNCT00107471Phase 1/2
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaCompletedNCT00107185Phase 1
- GW572016 to Treat Recurrent Malignant Brain TumorsCompletedNCT00107003Phase 2
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
- Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomasCompletedNCT00095771Phase 1
- Sorafenib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00093613Phase 1
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaCompletedNCT00089427Phase 1
- Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)CompletedNCT00087451Phase 1
- Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedNCT00087061Phase 1/2
- Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial GliomasStatus unknownNCT00083096Phase 1
- A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant GliomasCompletedNCT00080054Phase 1
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00079092Phase 2
- Alanosine in Treating Patients With Progressive or Recurrent Malignant GliomasCompletedNCT00075894Phase 1
- Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain TumorsStatus unknownNCT00075387Phase 2
- Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade GliomasCompletedNCT00074646Phase 1
- CC-8490 in Treating Patients With Recurrent or Refractory High-Grade GliomasCompletedNCT00074243Phase 1
- Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaCompletedNCT00070525Phase 2
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00068510Phase 1
- Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant GliomaCompletedNCT00064779Phase 1
- Talampanel in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00064363Phase 2
- Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
- The Role of Gene Changes in Brain Tumor Formation and GrowthCompletedNCT00059020
- FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
- Immunotoxin Therapy in Treating Children With Recurrent Malignant GliomasWithdrawnNCT00053040Phase 1/2
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
- Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaCompletedNCT00047281Phase 2
- Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant GliomaTerminatedNCT00045721Phase 1
- Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT00045565Phase 1
- Brachytherapy in Treating Patients With Recurrent Malignant GliomaCompletedNCT00045474Phase 1
- Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00041587Phase 1/2
- Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.CompletedNCT00040573Phase 1/2
- Imatinib Mesylate in Treating Patients With GliomasCompletedNCT00039364Phase 2
- Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant GliomasCompletedNCT00038441Phase 1/2
- Study of Vioxx and Radiation Therapy for Brainstem GliomaTerminatedNCT00038389Phase 1
- Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaCompletedNCT00036972Phase 1
- CC-5013 in Treating Patients With Recurrent GliomaCompletedNCT00036894Phase 1
- SarCNU in Treating Patients With Recurrent Malignant GliomaCompletedNCT00036660Phase 2
- This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.CompletedNCT00032903Phase 1/2
- Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaTerminatedNCT00031577Phase 1
- Genetic Analysis of Brain TumorsTerminatedNCT00031538
- Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV GliomasCompletedNCT00031083Phase 1
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine GliomaCompletedNCT00028795Phase 2
- Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain CancerCompletedNCT00028158Phase 1/2
- Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaCompletedNCT00027625Phase 1
- Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant GliomaCompletedNCT00024570Phase 1/2
- Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma PatientsCompletedNCT00024557Phase 1
- Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem GliomaStatus unknownNCT00024336Phase 2
- CCI-779 in Treating Patients With Malignant GliomaCompletedNCT00022724Phase 1/2
- Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
- Atrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00017264Phase 1
- Karenitecin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00014521Phase 1
- Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaTerminatedNCT00014443Phase 2
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
- Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaCompletedNCT00010049Phase 1/2
- Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain NeoplasmStatus unknownNCT00009854Phase 1/2
- Natural History of Patients With Brain and Spinal Cord TumorsCompletedNCT00009035
- Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaCompletedNCT00008008Phase 2
- Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic GliomaCompletedNCT00006474Phase 1
- Immunotoxin Therapy in Treating Patients With Malignant GliomaCompletedNCT00006268Phase 1/2
- Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade GliomaWithdrawnNCT00006263Phase 2
- Fenretinide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006080Phase 2
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
- Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent GliomaCompletedNCT00005976Phase 2
- Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00005951Phase 1
- Tipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00005859Phase 1/2
- Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00005855Phase 1/2
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
- Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem GliomasCompletedNCT00005602Phase 1
- Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaCompletedNCT00005082Not applicable
- Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00005081Phase 2
- O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004892Phase 1
- SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyCompletedNCT00004868Phase 1/2